LRRK2 and Parkinson disease: A recent study proposed GALC to also affect the risk of PD and suggested that its dysregulated activity might alter the composition of lysosomal membranes, which due to its involvement in the endolysosomal system links GALC directly to LRRK2 (Senkevich et al., 2023; Erb and Moore, 2020).